Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHS2200065	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2022-01-12		Chengdu Brilliant Pharmaceutical Co Ltd			view
CYHS2200066	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2022-01-12		Chengdu Brilliant Pharmaceutical Co Ltd			view
CYHS2300478	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2023-02-11		Chengdu Easton Bio Pharmaceuticals Co Ltd			view
CYHS2300479	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2023-02-11		Chengdu Easton Bio Pharmaceuticals Co Ltd			view
CYHS2301794	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2023-07-04		Reyoung Pharmaceutical Co Ltd			view
CYHS2301795	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2023-07-04		Reyoung Pharmaceutical Co Ltd			view
CYHS2302120	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2023-08-15		Hunan Kelun Pharmaceutical Co Ltd			view
CYHS2302557	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2023-09-22		Yaopharma Co Ltd			view
CYHS2303142	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2023-11-16		Kunshan Rotam Reddy Pharmaceutical Co Ltd			view
CYHS2303143	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2023-11-16		Kunshan Rotam Reddy Pharmaceutical Co Ltd			view
CYHS2401509	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2024-05-20		Shandong Langnuo Pharmaceutical Co Ltd			view
CYHS2401510	达可替尼片	dacomitinib	Tablet	Chemical Drugs(4)	Generic Drug	2024-05-20		Shandong Langnuo Pharmaceutical Co Ltd			view
JYHB1901169	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2019-09-23	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2019-10-08	view
JYHB1901170	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2019-09-23	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2019-10-08	view
JYHB1901427	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2019-12-04	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-01-02	view
JYHB1901428	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2019-12-04	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-01-02	view
JYHB2001899	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2020-09-29	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-10-16	view
JYHB2001900	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2020-09-29	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-10-16	view
JYHB2101072	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2021-05-13					view
JYHB2101073	达可替尼片	dacomitinib	Tablet	Chemical Drugs	Supplementary Application	2021-05-13					view